1. Home
  2. PPLI vs IRTC Comparison

PPLI vs IRTC Comparison

Compare PPLI & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo People Incorporated Common Stock

PPLI

People Incorporated Common Stock

N/A

Current Price

$41.45

Market Cap

3.5B

Sector

Technology

ML Signal

N/A

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$119.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPLI
IRTC
Founded
N/A
2006
Country
United States
United States
Employees
5156
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PPLI
IRTC
Price
$41.45
$119.49
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$197.92
AVG Volume (30 Days)
785.7K
514.9K
Earning Date
N/A
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
N/A
$19.60
Revenue Next Year
N/A
$15.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.24
52 Week Low
$41.05
$100.85
52 Week High
$48.32
$210.01

Technical Indicators

Market Signals
Indicator
PPLI
IRTC
Relative Strength Index (RSI) 44.70 60.72
Support Level $41.63 $119.48
Resistance Level $48.21 $129.33
Average True Range (ATR) 1.18 4.82
MACD -0.56 0.45
Stochastic Oscillator 7.85 92.91

Price Performance

Historical Comparison
PPLI
IRTC

About PPLI People Incorporated Common Stock

People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: